Royal Bank of Canada
PIII icon

Royal Bank of Canada’s P3 Health Partners PIII Stock Holding History

Royal Bank of Canada’s Portfolio PIII Stock Details PIII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$0 Hold
2
– – ﹤0.01% 7543
2025
Q4 		$0 Hold
2
– – ﹤0.01% 7511
2025
Q3 		$0 Hold
2
– – ﹤0.01% 7417
2025
Q2 		$0 Buy
+2
New +$16 ﹤0.01% 7259
2024
Q3 		– Sell
-31
Closed -$1K – 7287
2024
Q2 		$1K Buy
31
+12
+63% +$358 ﹤0.01% 6875
2024
Q1 		$1K Sell
19
-240
-93% -$13.3K ﹤0.01% 6841
2023
Q4 		$18K Buy
259
+46
+22% +$3.17K ﹤0.01% 6348
2023
Q3 		$16K Buy
213
+149
+233% +$15.5K ﹤0.01% 6260
2023
Q2 		$9K Buy
64
+11
+21% +$1.52K ﹤0.01% 6512
2023
Q1 		$2K Sell
53
-33
-38% -$1.98K ﹤0.01% 6788
2022
Q4 		$8K Buy
86
+80
+1,333% +$17.3K ﹤0.01% 6617
2022
Q3 		$1K Buy
6
+3
+100% +$750 ﹤0.01% 7241
2022
Q2 		$1K Sell
3
-25
-89% -$6.96K ﹤0.01% 7176
2022
Q1 		$11K Buy
+28
New +$8.4K ﹤0.01% 6910
2021
Q4 		– Hold
0
– – – 7832

Other funds holding PIII

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
TFA
Trinity Financial Advisors Columbus, Ohio $389M AUM 20.97% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return
Corient Private Wealth
Corient Private Wealth Miami, Florida $69.9B AUM 22.19% 1-Year Est. Return
NMC
Nine Masts Capital Central, Hong Kong $693M AUM 31.93% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Lido Advisors
Lido Advisors Los Angeles, California $32.7B AUM 19.2% 1-Year Est. Return

Royal Bank of Canada's PIII Position: Q1 2026 in Review

Royal Bank of Canada held its P3 Health Partners (PIII) position steady in Q1 2026 at 2 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #7543.

Royal Bank of Canada first reported a position in PIII in Q1 2022 and has held it in 14 quarters since. The position peaked at $18K in Q4 2023. 17 funds tracked by Wall St. Rank hold PIII as of Q1 2026.

  • Royal Bank of Canada held 2 shares of P3 Health Partners worth $0 as of Q1 2026.
  • Royal Bank of Canada left its P3 Health Partners share count unchanged in Q1 2026.
  • P3 Health Partners made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #7543 holding.
  • Royal Bank of Canada first reported a position in P3 Health Partners in Q1 2022 and has held it in 14 quarters since.
  • Royal Bank of Canada's P3 Health Partners position peaked at $18K in Q4 2023.
  • 17 funds tracked by Wall St. Rank held P3 Health Partners as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.